王 明誠

Medicine & Life Sciences

1. Angiotensin Receptor Antagonists 17%
2. Anti-Bacterial Agents 16%
3. Anti-Infective Agents 10%
4. Bacteremia 19%
5. Blood Pressure 19%
6. Carbapenems 13%
7. Catheters 11%
8. Chronic Kidney Failure 39%
9. Chronic Renal Insufficiency 94%
10. Cohort Studies 19%
11. Community-Acquired Infections 20%
12. Compliance 16%
13. Continuous Ambulatory Peritoneal Dialysis 16%
14. Diabetes Mellitus 10%
15. Dialysis 14%
16. Escherichia coli 72%
17. Fluoroquinolones 20%
18. Genes 17%
19. Incidence 14%
20. Infections 31%
21. Kidney 54%
22. Longitudinal Studies 13%
23. Microbial Drug Resistance 12%
24. Mortality 23%
25. Peritoneal Dialysis 54%
26. Peritonitis 43%
27. Plasmids 22%
28. Population 21%
29. Pyelonephritis 17%
30. Quinolones 19%
31. Renal Dialysis 49%
32. Type 1 Diabetes Mellitus 13%
33. University Hospitals 13%
34. Urinary Tract 11%
35. Urine 14%
36. Urolithiasis 12%
37. Uropathogenic Escherichia coli 24%
38. Virulence 25%
39. Virulence Factors 34%